Clinico-Epidemiologic Characteristics of Patients Reported in the Mycotic Infections in COVID-19 Registry

Rohan Maini; Neha Saini; Kranti Bhavana; Bhartendu Bharti; Shweta Walia; Neetu Kori; Sushila Kataria; Pooja Sharma; Vikas Deswal; Kavya Atluri; Yatin Sethi; Charuta Mandke; Mayank Chansoria; Sumit Rawat; Rajani Bhat; Ameet Dravid; Chandan Baranwal; Nirmal Sarkar; Sunit Jariwala; Yoram Puius; Shitij Arora

doi:10.4269/ajtmh.22-0503

Clinico-Epidemiologic Characteristics of Patients Reported in the Mycotic Infections in COVID-19 Registry

Rohan Maini, Neha Saini, Kranti Bhavana, Bhartendu Bharti, Shweta Walia, Neetu Kori, Sushila Kataria, Pooja Sharma, Vikas Deswal, Kavya Atluri, Yatin Sethi, Charuta Mandke, Mayank Chansoria, Sumit Rawat, Rajani Bhat, Ameet Dravid, Chandan Baranwal, Nirmal Sarkar, Sunit Jariwala, Yoram PuiusShitij Arora

Medicine

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

We update results from the Mycotic Infections in COVID-19 (MUNCO) Registry, May–September 2021. Data collection from May to September 2021 yielded 728 cases from India, Nepal, Bangladesh, Thailand, and the United States. The cases consisted of mostly mucormycosis (97.6%), primarily rhinocerebral, and were analyzed to investigate clinical characteristics associated with negative outcomes. Patients were mostly diabetic (85%) and male (76%), with significant mortality (11.7%). All patients received treatment of coronavirus disease 2019 (COVID-19) as well as antifungal treatment. The crude mortality rate was 11.3% for mucormycosis and 22.7% formixed infections. This study demonstrates the utility of online databases in the collection of high-caliber data.

Original language	English (US)
Pages (from-to)	584-587
Number of pages	4
Journal	American Journal of Tropical Medicine and Hygiene
Volume	108
Issue number	3
DOIs	https://doi.org/10.4269/ajtmh.22-0503
State	Published - Mar 2023

ASJC Scopus subject areas

Parasitology
Infectious Diseases
Virology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.4269/ajtmh.22-0503

Cite this

Maini, R., Saini, N., Bhavana, K., Bharti, B., Walia, S., Kori, N., Kataria, S., Sharma, P., Deswal, V., Atluri, K., Sethi, Y., Mandke, C., Chansoria, M., Rawat, S., Bhat, R., Dravid, A., Baranwal, C., Sarkar, N., Jariwala, S., ... Arora, S. (2023). Clinico-Epidemiologic Characteristics of Patients Reported in the Mycotic Infections in COVID-19 Registry. American Journal of Tropical Medicine and Hygiene, 108(3), 584-587. https://doi.org/10.4269/ajtmh.22-0503

Maini, R, Saini, N, Bhavana, K, Bharti, B, Walia, S, Kori, N, Kataria, S, Sharma, P, Deswal, V, Atluri, K, Sethi, Y, Mandke, C, Chansoria, M, Rawat, S, Bhat, R, Dravid, A, Baranwal, C, Sarkar, N, Jariwala, S , Puius, Y & Arora, S 2023, 'Clinico-Epidemiologic Characteristics of Patients Reported in the Mycotic Infections in COVID-19 Registry', American Journal of Tropical Medicine and Hygiene, vol. 108, no. 3, pp. 584-587. https://doi.org/10.4269/ajtmh.22-0503

@article{161ca2407927497d83ca6e9dba32fe80,

title = "Clinico-Epidemiologic Characteristics of Patients Reported in the Mycotic Infections in COVID-19 Registry",

abstract = "We update results from the Mycotic Infections in COVID-19 (MUNCO) Registry, May–September 2021. Data collection from May to September 2021 yielded 728 cases from India, Nepal, Bangladesh, Thailand, and the United States. The cases consisted of mostly mucormycosis (97.6%), primarily rhinocerebral, and were analyzed to investigate clinical characteristics associated with negative outcomes. Patients were mostly diabetic (85%) and male (76%), with significant mortality (11.7%). All patients received treatment of coronavirus disease 2019 (COVID-19) as well as antifungal treatment. The crude mortality rate was 11.3% for mucormycosis and 22.7% formixed infections. This study demonstrates the utility of online databases in the collection of high-caliber data.",

author = "Rohan Maini and Neha Saini and Kranti Bhavana and Bhartendu Bharti and Shweta Walia and Neetu Kori and Sushila Kataria and Pooja Sharma and Vikas Deswal and Kavya Atluri and Yatin Sethi and Charuta Mandke and Mayank Chansoria and Sumit Rawat and Rajani Bhat and Ameet Dravid and Chandan Baranwal and Nirmal Sarkar and Sunit Jariwala and Yoram Puius and Shitij Arora",

note = "Publisher Copyright: Copyright {\textcopyright} 2023 The author(s)",

year = "2023",

month = mar,

doi = "10.4269/ajtmh.22-0503",

language = "English (US)",

volume = "108",

pages = "584--587",

journal = "American Journal of Tropical Medicine and Hygiene",

issn = "0002-9637",

publisher = "American Society of Tropical Medicine and Hygiene",

number = "3",

}

TY - JOUR

T1 - Clinico-Epidemiologic Characteristics of Patients Reported in the Mycotic Infections in COVID-19 Registry

AU - Maini, Rohan

AU - Saini, Neha

AU - Bhavana, Kranti

AU - Bharti, Bhartendu

AU - Walia, Shweta

AU - Kori, Neetu

AU - Kataria, Sushila

AU - Sharma, Pooja

AU - Deswal, Vikas

AU - Atluri, Kavya

AU - Sethi, Yatin

AU - Mandke, Charuta

AU - Chansoria, Mayank

AU - Rawat, Sumit

AU - Bhat, Rajani

AU - Dravid, Ameet

AU - Baranwal, Chandan

AU - Sarkar, Nirmal

AU - Jariwala, Sunit

AU - Puius, Yoram

AU - Arora, Shitij

PY - 2023/3

Y1 - 2023/3

N2 - We update results from the Mycotic Infections in COVID-19 (MUNCO) Registry, May–September 2021. Data collection from May to September 2021 yielded 728 cases from India, Nepal, Bangladesh, Thailand, and the United States. The cases consisted of mostly mucormycosis (97.6%), primarily rhinocerebral, and were analyzed to investigate clinical characteristics associated with negative outcomes. Patients were mostly diabetic (85%) and male (76%), with significant mortality (11.7%). All patients received treatment of coronavirus disease 2019 (COVID-19) as well as antifungal treatment. The crude mortality rate was 11.3% for mucormycosis and 22.7% formixed infections. This study demonstrates the utility of online databases in the collection of high-caliber data.

AB - We update results from the Mycotic Infections in COVID-19 (MUNCO) Registry, May–September 2021. Data collection from May to September 2021 yielded 728 cases from India, Nepal, Bangladesh, Thailand, and the United States. The cases consisted of mostly mucormycosis (97.6%), primarily rhinocerebral, and were analyzed to investigate clinical characteristics associated with negative outcomes. Patients were mostly diabetic (85%) and male (76%), with significant mortality (11.7%). All patients received treatment of coronavirus disease 2019 (COVID-19) as well as antifungal treatment. The crude mortality rate was 11.3% for mucormycosis and 22.7% formixed infections. This study demonstrates the utility of online databases in the collection of high-caliber data.

UR - http://www.scopus.com/inward/record.url?scp=85149171940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85149171940&partnerID=8YFLogxK

U2 - 10.4269/ajtmh.22-0503

DO - 10.4269/ajtmh.22-0503

M3 - Article

C2 - 36535246

AN - SCOPUS:85149171940

SN - 0002-9637

VL - 108

SP - 584

EP - 587

JO - American Journal of Tropical Medicine and Hygiene

JF - American Journal of Tropical Medicine and Hygiene

IS - 3

ER -

Clinico-Epidemiologic Characteristics of Patients Reported in the Mycotic Infections in COVID-19 Registry

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this